Ascend Wellness Holdings (AAWH) Cash from Investing Activities (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Cash from Investing Activities of -$4.8 million for Q1 2026, up 39.43% year-over-year from -$3.4 million in Q1 2025, and up 71.65% quarter-over-quarter from -$16.8 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$4.8 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 39.43% year-over-year to -$4.8 million; the TTM figure through Mar 2026 stood at -$42.6 million (up 0.96% YoY), while the FY2025 annual figure was -$45.7 million, down 22.96% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$4.8 million, up from -$16.8 million in the prior quarter.
- The five-year high for Cash from Investing Activities was -$622000.0 in Q1 2022, with the low at -$47.7 million in Q2 2022.
- The 5-year median for Cash from Investing Activities is -$11.1 million (2024), against an average of -$15.4 million.
- The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities surged 98.23% in 2022, then plunged 813.02% in 2023.
- Ascend Wellness Holdings' Cash from Investing Activities stood at -$19.7 million in 2022, then surged by 58.62% to -$8.2 million in 2023, then increased by 11.8% to -$7.2 million in 2024, then sank by 133.08% to -$16.8 million in 2025, then surged by 71.65% to -$4.8 million in 2026.
- Business Quant data shows AAWH's Cash from Investing Activities at -$4.8 million in Q1 2026, -$16.8 million in Q4 2025, and -$12.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Ascend Wellness Holdings | 95.41 Mn | 28.41 Mn | 45.49 Mn | -13.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.09 Mn |
| Jun 30, 2026 | -13.09 Mn |
| Mar 31, 2026 | -4.75 Mn |
| Mar 31, 2026 | -4.75 Mn |
| Dec 31, 2025 | -16.76 Mn |
| Dec 31, 2025 | -16.76 Mn |
| Sep 30, 2025 | -12.54 Mn |
| Sep 30, 2025 | -12.54 Mn |
| Jun 30, 2025 | -8.59 Mn |
| Jun 30, 2025 | -8.59 Mn |
| Mar 31, 2025 | -7.85 Mn |
| Mar 31, 2025 | -7.85 Mn |
| Dec 31, 2024 | -7.19 Mn |
| Dec 31, 2024 | -7.19 Mn |
| Sep 30, 2024 | -11.14 Mn |
| Sep 30, 2024 | -11.14 Mn |
| Jun 30, 2024 | -16.88 Mn |
| Jun 30, 2024 | -16.88 Mn |
| Mar 31, 2024 | -1.99 Mn |
| Mar 31, 2024 | -1.99 Mn |